Free Trial
LON:GDR

genedrive (GDR) Share Price, News & Analysis

genedrive logo
GBX 2.41
+0.03 (+1.05%)
(As of 11:49 AM ET)

About genedrive Stock (LON:GDR)

Key Stats

Today's Range
2.20
2.58
50-Day Range
1.79
2.93
52-Week Range
1.41
12.30
Volume
8.30 million shs
Average Volume
14.26 million shs
Market Capitalization
£13.11 million
P/E Ratio
N/A
Dividend Yield
1.57%
Price Target
N/A
Consensus Rating
N/A

Company Overview

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

Receive GDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for genedrive and its competitors with MarketBeat's FREE daily newsletter.

GDR Stock News Headlines

Genedrive Share Chat (GDR)
ANGLE plc (DWV.F)
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Turkiye Gdr Rgs Share Chat
Reliance Industries Ltd GDR - 144A RIGD
See More Headlines

GDR Stock Analysis - Frequently Asked Questions

genedrive's stock was trading at GBX 8.13 at the beginning of 2024. Since then, GDR stock has decreased by 70.3% and is now trading at GBX 2.41.
View the best growth stocks for 2024 here
.

genedrive plc (LON:GDR) issued its earnings results on Tuesday, February, 4th. The company reported ($8.90) EPS for the quarter.

Shares of GDR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that genedrive investors own include Rolls-Royce Holdings plc (RR.L), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

Last Earnings
2/04/2020
Today
11/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
43
Year Founded
N/A

Profitability

Net Income
£-5,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£49,000.00
Cash Flow
GBX 1.21 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£13.11 million
Optionable
Not Optionable
Beta
-0.04
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:GDR) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners